CJ

Corinne Jenkins

#144 out of 1699 analysts
Goldman Sachs
Automatically Tracked
Tracking: 0 Updated: Jun 15 at 02:14 PM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
55.27%
Gain +1.47%
Monthly
1.26%
Yearly
16.21%
Drawdown
29.02%
$255,877.06
Equity
Holdings
$0
Cash
$255,877.06
Investment
$0
$107,491.05
Profit +$3,716.03
Realized
$107,491.05
Unrealized
$0
Dividends
$0
$255,877.06
Cash
Deposits
$148,386.02
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.47%
Profit
$3,716.03
Win %
66%
This Week
Compared To Last Week
Gain
-1%
Profit
-$2,578.47
Win %
40%
This Month
Compared to last month
Gain
-4.86%
Profit
-$13,066.89
Win %
40%
This Year
Compared to last year
Gain
5.06%
Profit
$12,313.56
Win %
40%
Roivant Sciences Ltd logo
ROIV Roivant Sciences Ltd
+$55,750.02
TG Therapeutics, Inc. logo
TGTX TG Therapeutics, Inc.
+$16,488.88
Altimmune, Inc. logo
ALT Altimmune, Inc.
+$16,057.95
Geron Corporation logo
GERN Geron Corporation
+$15,993.29
Ideaya Biosciences Inc. logo
IDYA Ideaya Biosciences Inc.
+$9,518.67
Fulcrum Therapeutics Inc. logo
FULC Fulcrum Therapeutics Inc.
+$8,266.72
Harmony Biosciences Holdings, Inc. logo
HRMY Harmony Biosciences Holdings, Inc.
+$1,035.72
Rhythm Pharmaceuticals Inc. logo
RYTM Rhythm Pharmaceuticals Inc.
-$8,118.45
Aclaris Therapeutics, Inc. logo
ACRS Aclaris Therapeutics, Inc.
-$7,501.76
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
117
Longs Won
44/94 46%
Profit Factor
1.93
Profitability
Shorts Won
16/23 69%
Standard Deviation
$6,139.98
Average Win
$3,710.21
Best Trade
(Mar 25) $42,890.63
Sharpe Ratio
-92.65
Average Loss
-$2,019.68
Worst Trade
(Mar 15) -$20,191.45
Z-Score
-1.29 (80.6%)
Commissions
$0
Avg. Trade Length
1m 3w 3d
Expectancy
$918.73
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% 0.02% 0.18% 1.23% 6.39% 27.3%
Consecutive Losing Trades 127 114 101 89 76 63 51 38 25 13
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV